All In MedTech

FDA Clearance Tracker · P040026

ORTHOSPEC EXTRACORPOREAL SHOCK WAVE THERAPY DEVICE

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 19, 2026Latest source record: Apr 1, 2005 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Apr 1, 2005

Approved

Time to decision

301 days

Received Jun 4, 2004. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P040026
Device name
ORTHOSPEC EXTRACORPOREAL SHOCK WAVE THERAPY DEVICE
Applicant location
Gaithersburg, MD
Received
Jun 4, 2004
Decided
Apr 1, 2005
Decision
Approved

Device type

Device class
Class III

Every decision under product code NBN

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE ORTHOSPEC EXTRACORPOREAL SHOCK WAVE THERAPY DEVICE. THE DEVICE IS INDICATED FOR THE TREATMENT OF PROXIMAL PLANTAR FASCIITIS WITH OR WITHOUT HEEL SPUR IN PATIENTS 18 YEARS OF AGE OR OLDER. THE ORTHOSPEC EXTRACORPOREAL SHOCK WAVE THERAPY IS A NON-INVASIVE ALTERNATIVE METHOD FOR PATIENT WITH SYMPTOMS OF PROXIMAL PLANTAR FASCIITIS FOR 6 MONTHS OR MORE AND A HISTORY OF UNSUCCESSFUL CONSERVATIVE THERAPIES TO RELIEVE HEEL PAIN. PROXIMAL PLANTAR FASCIITIS IS DEFINED AS HEEL PAIN IN THE AREA OF THE INSERTION OF THE PLANTAR FASCIA ON THE PLANTAR CALCANEAL TUBEROSITY.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code NBN. The earliest in FDA's data is P990086, decided Oct 12, 2000.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Medispec, Ltd.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.